ArticleChembiochem : a European journal of chemical biology2026

Heat Shock Protein Inhibitor Tanespimycin (17AAG) Suppresses SARS-CoV-2 Main Protease Activity and Is More Potent Than Clinically Approved Antiviral Nirmatrelvir.

Gargi Mukherjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.